Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giulio Cossu

Showing results (71-80 of 154) with videos related to

Pageof 16
Sort By:
Experimental Cell Research|October 22, 2003
Skeletal myogenic progenitors in the endothelium of lung and yolk sacMaria Gabriella Cusella De Angelis, Giovanna Balconi, Sergio Bernasconi, et al.
The Journal of Cell Biology|January 13, 2006
Follistatin induction by nitric oxide through cyclic GMP: a tightly regulated signaling pathway that controls myoblast fusionAddolorata Pisconti, Silvia Brunelli, Monica Di Padova, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 28, 2007
Stem and progenitor cells in skeletal muscle development, maintenance, and therapyBruno Péault, Michael Rudnicki, Yvan Torrente, et al.
Plos One|June 19, 2008
Binding of sFRP-3 to EGF in the extra-cellular space affects proliferation, differentiation and morphogenetic events regulated by the two moleculesRaffaella Scardigli, Cesare Gargioli, Daniela Tosoni, et al.
Developmental Cell|March 13, 2013
Dll4 and PDGF-BB convert committed skeletal myoblasts to pericytes without erasing their myogenic memoryOrnella Cappellari, Sara Benedetti, Anna Innocenzi, et al.
The Journal of Cell Biology|July 13, 2006
Complete repair of dystrophic skeletal muscle by mesoangioblasts with enhanced migration abilityBeatriz G Galvez, Maurilio Sampaolesi, Silvia Brunelli, et al.
Human Gene Therapy. Clinical Development|July 19, 2013
The committee for advanced therapies' of the European Medicines Agency reflection paper on management of clinical risks deriving from insertional mutagenesisAlessandro Aiuti, Giulio Cossu, Pablo de Felipe, et al.
Cell Death and Differentiation|May 27, 2006
Reversine-treated fibroblasts acquire myogenic competence in vitro and in regenerating skeletal muscleLuigi Anastasia, Maurilio Sampaolesi, Nadia Papini, et al.
Genes & Development|August 5, 2008
A highly conserved molecular switch binds MSY-3 to regulate myogenin repression in postnatal muscleLibera Berghella, Luciana De Angelis, Tristan De Buysscher, et al.
Cell Transplantation|April 25, 2012
Bystander effect on brain tissue of mesoangioblasts producing neurotrophinsTao Su, Raffaella Scardigli, Luisa Fasulo, et al.
Pageof 16

Showing results (71-80 of 154) with videos related to

Sort By:
Pageof 16
Experimental Cell Research|October 22, 2003
Skeletal myogenic progenitors in the endothelium of lung and yolk sacMaria Gabriella Cusella De Angelis, Giovanna Balconi, Sergio Bernasconi, et al.
The Journal of Cell Biology|January 13, 2006
Follistatin induction by nitric oxide through cyclic GMP: a tightly regulated signaling pathway that controls myoblast fusionAddolorata Pisconti, Silvia Brunelli, Monica Di Padova, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 28, 2007
Stem and progenitor cells in skeletal muscle development, maintenance, and therapyBruno Péault, Michael Rudnicki, Yvan Torrente, et al.
Plos One|June 19, 2008
Binding of sFRP-3 to EGF in the extra-cellular space affects proliferation, differentiation and morphogenetic events regulated by the two moleculesRaffaella Scardigli, Cesare Gargioli, Daniela Tosoni, et al.
Developmental Cell|March 13, 2013
Dll4 and PDGF-BB convert committed skeletal myoblasts to pericytes without erasing their myogenic memoryOrnella Cappellari, Sara Benedetti, Anna Innocenzi, et al.
The Journal of Cell Biology|July 13, 2006
Complete repair of dystrophic skeletal muscle by mesoangioblasts with enhanced migration abilityBeatriz G Galvez, Maurilio Sampaolesi, Silvia Brunelli, et al.
Human Gene Therapy. Clinical Development|July 19, 2013
The committee for advanced therapies' of the European Medicines Agency reflection paper on management of clinical risks deriving from insertional mutagenesisAlessandro Aiuti, Giulio Cossu, Pablo de Felipe, et al.
Cell Death and Differentiation|May 27, 2006
Reversine-treated fibroblasts acquire myogenic competence in vitro and in regenerating skeletal muscleLuigi Anastasia, Maurilio Sampaolesi, Nadia Papini, et al.
Genes & Development|August 5, 2008
A highly conserved molecular switch binds MSY-3 to regulate myogenin repression in postnatal muscleLibera Berghella, Luciana De Angelis, Tristan De Buysscher, et al.
Cell Transplantation|April 25, 2012
Bystander effect on brain tissue of mesoangioblasts producing neurotrophinsTao Su, Raffaella Scardigli, Luisa Fasulo, et al.
Pageof 16